Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis (WRNMMC)
This study is currently recruiting participants.
Verified August 2012 by U.S. Army Medical Research and Materiel Command
Study NCT01140191   Information provided by U.S. Army Medical Research and Materiel Command

First Received on June 7, 2010.   Last Updated on August 17, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leishmaniasis, Cutaneous
Additional conditions recognized in this trial
Leishmaniasis
More general conditions related to this trial
Euglenozoa Infections
Parasitic Diseases
Protozoan Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
WR 279,396
Additional drug interventions recognized in this trial
Gentamicins
Paromomycin
More general drug interventions related to this trial
Amebicides
Anti-Bacterial Agents
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protein Synthesis Inhibitors
Therapeutic Uses
Sponsors listed in this trial
U.S. Army Medical Research and Materiel Command
Walter Reed National Military Medical Center
Walter Reed Army Institute of Research (WRAIR)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services